A new US and international clinical trials network has been launched, with the goal of accelerating recruitment for large-scale trials of vaccine candidates and investigational monoclonal antibodies against COVID-19.
Launched under the auspices of the US government's Operation Warp Speed and the National Institutes of Health (NIH) and National Institute of Allergy and Infectious Diseases (NIAID), the network is meant to address the fragmented nature of COVID-19
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?